Global HIV Market: An Analysis
| Publication Date | February 2009 |
|---|---|
| Publisher | Koncept Analytics |
| Product Type | Report |
| Pages | 25 |
| ISBN Number | not applicable |
| Product Code | KOA04341 |
Buy this product or for assistance call +44 20 7060 7474
Summary
HIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment for HIV which has made a separate market for HIV drugs. The HIV drug market is increasing due to increasing awareness and diagnosis rates. There are around five million people in low and middle income countries who do not have access to AIDS drugs. HIV is very common in Southern African region. Botswana and Zimbabwe are the most affected countries; HIV is the most underlying reason for more than one third of all deaths among children under age of five.
In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment.
The report outlines major countries affected from HIV virus and death rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan Africa. It highlights major markets for HIV drugs with overall market value and major drugs revenue.
The report discusses the opportunities prevailing in the HIV drugs market and issues affecting the growth. It also talks about competition prevalent in the market. It profiles major players with an overview of their business, key financials and business strategies.
Content
- 1. Industry Overview
- 1.1 Introduction
- 1.2 Treatment for HIV
- 2. Market Size
- 2.1 Global HIV Market
- HIV/AIDS Cases
- 2.2 United States
- HIV/AIDS Cases by Region
- AIDS Diagnoses
- 2.3 Sub-Saharan Africa
- 2.4 United Kingdom
- Diagnosed Cases
- HIV Infected Persons by Region
- 2.5 Asia
- 2.1 Global HIV Market
- 3. HIV Drugs Market
- Market Value
- Drug Revenue Comparison
- 4. Market Trends
- 4.1 Opportunities in HIV Drug Market
- Opportunities in Japan
- Increasing Number of Cases Leads to Increase in Drug Demand
- Increasing Demand of Sexual Health Services
- 4.2 Key Issues
- Policy & Programme Development
- Capacity of Communities
- Raising Awareness
- Gender Issues
- 4.1 Opportunities in HIV Drug Market
- 5. Major Market Players
- 5.1 Competition
- Major Players Growth Comparison
- 5.2 Company Profiles
- 5.2.1 Gilead Science
- Overview
- Business Strategies
- Maintaining Leadership in HIV/AIDS Treatment
- Expanded Product Portfolio
- Strategic Partnerships
- 5.2.2 Idenix Pharmaceuticals
- Overview
- Business Strategies
- Restructuring Program
- Strong Patent Portfolio
- 5.2.3 Bristol Myers Squibb
- Overview
- Business Strategies
- Productivity Transformation Initiative
- 5.2.1 Gilead Science
- 5.1 Competition
- 6. Market Forecast
- People Receiving Therapy Projections
- List of Tables
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
- Protease Inhibitors (PIs)
- HIV/AIDS Worldwide Cases/Deaths (2007)
- US AIDS Diagnosis (2006)
- Transmission Category of HIV (2006)
- Sub-Saharan Africa Cases/Deaths (2007)
- HIV/AIDS Diagnosed Cases in UK by Gender (2000-08)
- HIV/AIDS Diagnosed Cases in UK by Region (2000-08)
- China AIDS Statistics (2007)
- Major Players Growth Comparison (2007)
- Gilead Revenue by Geography (2005-07)
- Idenix Revenue by Products (2006-07)
- Bristol-Myers Squibb Revenue by Business Segments (2005-07)
- First-line Therapy Projections (2008-13E)
- People Receiving Antiretroviral Therapy (2006-08E)
- List of Charts
- Worldwide HIV/AIDS Cases (2006)
- Children Living with HIV Globally (2007)
- Top Ten Reported AIDS Cases in US by Region (2006)
- HIV Prevalence in Pakistan by Region (2007)
- Global HIV Drugs Market (2004-07)
- Global HIV Drugs Revenue Comparison (2006)
- Global HIV Drugs Revenue Comparison (2007)
- Ranking of America's Largest Pharma Corporations (2007)
- Top Biotechnology Companies (2006)
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
Product features / use
| Scope | Comprehensive Overview | ![]() |
| Level | General Industry Strategies | ![]() |
| Data | Broad Market Predictions | ![]() |
| Profiles | Profiles of Key Companies | ![]() |
| Features | Future Consumer Trends | ![]() |
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories












